Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
Actual shortage: | 46 (10%) | |
Anticipated shortage: | 15 (3%) | |
Avoided shortage: | 8 (2%) | |
Resolved: | 376 (84%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (18%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
LACOSAMIDE | 100MG | TABLET | Resolved | 2023-07-31 | 2023-11-06 | 200437 |
RIZATRIPTAN | 10MG | TABLET | Resolved | 2023-07-31 | 2023-08-28 | 200440 |
GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-07-31 | 2024-01-30 | 200443 |
MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2023-07-31 | 2023-08-29 | 200446 |
ATOMOXETINE | 100MG | CAPSULE | Resolved | 2023-07-31 | 2023-08-29 | 200453 |
OLMESARTAN | 40MG | TABLET | Resolved | 2023-07-31 | 2023-09-25 | 200456 |
SOLIFENACIN | 10MG | TABLET | Resolved | 2023-07-31 | 2024-02-12 | 200459 |
OLMESARTAN | 20MG | TABLET | Resolved | 2023-07-31 | 2024-01-17 | 200465 |
DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-07-31 | 2023-12-02 | 200468 |
BACLOFEN | 10MG | TABLET | Resolved | 2023-07-31 | 2023-11-27 | 200471 |
TADALAFIL | 20MG | TABLET | Resolved | 2023-07-31 | 2023-12-26 | 200474 |
TADALAFIL | 5MG | TABLET | Resolved | 2023-07-31 | 2023-12-26 | 200477 |
DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-08-22 | 2024-01-30 | 202687 |
PREGABALIN | 150MG | CAPSULE | Resolved | 2023-08-22 | 2023-09-06 | 202695 |
PREGABALIN | 50MG | CAPSULE | Resolved | 2023-08-29 | 2023-11-13 | 203109 |
TRAZODONE | 150MG | TABLET | Resolved | 2023-08-29 | 2023-09-10 | 203118 |
PROGESTERONE | 100MG | CAPSULE | Resolved | 2023-08-29 | 2023-09-25 | 203121 |
BACLOFEN | 20MG | TABLET | Resolved | 2023-08-29 | 2023-09-25 | 203125 |
GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-08-29 | 2023-10-23 | 203128 |
PREGABALIN | 75MG | CAPSULE | Resolved | 2023-08-29 | 2023-11-06 | 203135 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |